Representing and supporting medical oncologists in the UK

ACP Immunotherapy Workshop

13 October 2017, Renaissance Manchester City Centre Hotel

0900 Registration
0945 Welcome
Chair: Dr Ruth Board, Royal Preston Hospital
0950 Immunotherapy - past, present and future
Professor Peter Johnson, University of Southampton
1015 Checkpoint Inhibitors  
To be confirmed
1045 Managing Toxicity of Immunotherapy 
Dr James Larkin, Royal Marsden
1115 Break
1130 Adoptive Cell Therapy for Solid Tumours
Dr Sophie Papa, Guy's Hospital
1200 Vaccines
Professor Peter Selby, St James University Hospital
1230 Lunch
  Afternoon Session
Chair: Dr Fiona Thistlethwaite, Christie Hospital
1330 Combination Immunotherapies- Multimodality treatment
Dr Paul Nathan, Mount Vernon Hospital
1400 Predicting response to Immunotherapy
Professor Christian Ottensmeier, Southampton Royal
1430 Immunotherapy- can we afford it?
Dr Peter Hall, Edinburgh Western Hospital
1500 Break
  Case Histories
1515 Round 1
Chair: Peter Selby
Panel: Sophie Papa, Peter Selby, Fiona Thistlethwaite
  1. Cytokine Release Syndrome
    Charlotte Graham, CRF, King’s College London
  2. High dose IL2/TILS
Manon Evans, SPR, Christie Hospital
1545 Round 2
Chair: Paul Nathan
Panel: Paul Nathan, James Larkin
  1. Multiorgan toxicity following combination immunotherapy treatment in melanoma
Lavinia Spain, SpR, Royal Marsden
  2. Endocrine Toxicity with checkpoint Inhibitor
    Alec Pashalis, SpR, Southampton Royal
1625 Summary
Dr Ruth Board, Royal Preston Hospital
1640 Close





























Submitted for approval by the Federation of the Royal Colleges of Physicians of the United Kingdom for 6 category 1 (external) credits (code 99395)